A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ...

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't some cure-all.

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: CSA Images via ...

The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...

A new type of blood test that checks for signs of cancer in healthy people has hit the market. But it's still unclear whether these screening tests will make any difference in cancer death rates. Such ...

Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood that could replace invasive biopsies and catch tumors when they are still ...

For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, ...

For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, ...

Cancer is the No. 1 cause of line-of-duty deaths among firefighters, who are 9% more likely than the general population to be ...